Johan Quintens

Johan Quintens currently serves as Chief Scientific Officer at Inteliphage, where responsibilities include overseeing the development of innovative treatments for antibiotic-resistant infections through personalized bacteriophage therapy and a proprietary automated diagnostic test. In addition, Johan has held the position of Director at Vesale Pharma since January 2001, contributing to the company's strategic direction and operations in the pharmaceutical industry.